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  Abstract 
Child obesity and overweight increase dramatically in Sweden and globally. Studies 
show besides genetics, that lifestyle such as parental feeding behaviors have a sig-
nificant impact on the weight of the children. Whole grain (WG) intake has been 
associated with reduced risk of developing type 2 diabetes, cardiovascular diseases 
(CVD) and their preconditions or risk factors, such as weight gain, blood pressure 
and inflammation. The inverse association with weight is emphasized in several 
observational studies, whereas a few intervention studies show no or marginal 
weight loss. Hitherto, no intervention studies on the role of WG intake for body 
weight management in children have been conducted. Alkylresorcinols (AR) are 
lipophilic phenolic compounds found mainly in the bran of rye and wheat among 
commonly consumed foods, which makes them to suitable biomarkers for WG 
intake. The ratio between the two homologues C17:0 and C21:0 shows the origin of 
the WG (~1.0 rye, ~0.1 common wheat and ~0.01 durum wheat). The early Stock-
holm Obesity Prevention Program (STOPP) is an ongoing intervention study on 
families with two overweight parents or one obese parent and their children. The 
intervention started when the children were one year old and will continue until the 
age of six, with continuous examinations and blood sampling after one, three and 
six years. Coaches have been used in order to introduce the families to a healthier 
lifestyle, steadier sleeping patterns and a healthier diet. The aim of the present study 
was to examine AR concentrations in plasma, as a biomarker of WG wheat and rye 
intake and was associated with changes in body mass index (BMI) of the subjects in 
the Early STOPP-study. Plasma samples has previously been analyzed from the 
first year in the intervention, when the infants were one year old. In this study, 
plasma samples were analyzed from the families when the children were three years 
old. The results showed that the AR in the plasma were not associated with BMI of 
the children. Moderate positive correlations for total AR in plasma were found 
between the 3-year old children and the mothers and fathers at the 1-year follow-up, 
as well as the fathers at the 3-year follow-up, which could imply that the AR 
reflects the true WG intake for 3-year old children.  However, the self-declared WG 
intake did not correlate with the measured AR concentrations in the plasma, most 
likely due to the impact of other non-dietary determinants of plasma AR concentra-
tions in small children. This implies that AR are not suitable as biomarkers of WG 
intake in children. 
Keywords: Alkylresorcinols, Obesity, Overweight, Whole grain rye, Whole grain 
wheat, Whole grains, C17:0/C21:0  
Sammanfattning 
Barnfetma och -övervikt ökar dramatiskt i Sverige och i världen. Studier visar att 
utöver gener, så har livsstilsfaktorer, såsom föräldrarnas matningsrutiner, en signi-
fikant effekt på barnens vikt. Fullkornsintag har blivit associerat med reducerad risk 
för att utveckla diabetes typ 2 och hjärt- och kärlsjukdomar genom att förhindra 
riskfaktorer som viktuppgång, högt blodtryck och inflammationer. Att fullkorn 
förhindrar viktuppgång är påvisat i flera observationsstudier, dock visar ett fåtal 
interventionsstudier ingen eller en marginell viktnedgång. Än så länge har inga 
interventionsstudier genomförts för att observera fullkornets roll i viktkontroll hos 
barn. Alkylresorcinoler (AR) är fettlösliga fenoler, främst förekommande i råg- och 
vetekli bland vanliga livsmedel, vilket gör dem till passande biomarkörer för full-
kornsintag. Ration mellan de två homologerna C17:0 och C21:0 avslöjar fullkorns-
källan (~1,0 råg, ~0,1 vete och ~0,01 durumvete). Early Stockholm Obesity Pre-
vention Program (STOPP) är en pågående interventionsstudie på familjer med två 
överviktiga föräldrar eller en fet förälder och deras barn. Interventionsstudien bör-
jade när barnen var ett år gamla och kommer pågå till att de är sex år gamla, med 
kontinuerliga utvärderingar och blodprovstagningar efter ett, tre och sex år. Coacher 
har introducerat familjerna till en hälsosammare livsstil, mer regelbundna sömnruti-
ner och en hälsosammare diet. I denna studie uppmättes koncentrationer av AR i 
plasman hos Early STOPP-deltagarna, för att undersöka relationen mellan intaget 
av fullkornsråg och – vete och förändringar av body mass index (BMI). Plasmapro-
ver har tidigare blivit analyserade från första året i interventionen, när barnen var ett 
år gamla. I denna studie analyserades plasmaprover från familjerna när barnen var 
tre år gamla. Resultatet visade att AR i plasman inte var associerat med barnens 
BMI. Måttliga positiva korrelationer för total AR i plasman kunde observeras 
mellan barnen år tre och föräldrarna i 1-årsuppföljningen, samt med papporna i 3-
årsuppföljningen, vilket kan tyda på att AR reflekterar fullkornsintaget för 3-åriga 
barn. Dock korrelerade inte det självdeklarerade fullkornsintaget med de uppmätta 
AR-koncentrationerna i plasman, förmodligen på grund av icke-kostrelaterade fak-
torers inverkan på AR-koncentrationerna hos små barn. Detta tyder på att AR inte 
är lämpliga som biomarkörer för fullkornsintag hos barn. 
Nyckelord: Alkylresorcinoler, Fetma, Övervikt, Fullkornsråg, Fullkornsvete, Full-
korn, C17:0/C21:0 
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1 Background 
1.1   Overweight and obesity 
  Overweight and obesity are considered to be epidemic diseases that occur not 
only in the industrialized parts of the world, but also in the developing countries. 
Worldwide, obesity has more than doubled the past 35 years (WHO, 2015a) and 
there is no indication of a retrenchment (OECD, 2014). The prevalence of over-
weight and obesity is highest among Americans (61 % overweight and 27 % obe-
sity) and lowest among South East Asians (22 % overweight and 5 % obesity) 
(WHO, 2015b). “Globesity” (global obesity) is one of the most severe health prob-
lems mankind is dealing with, considering all the health related complications that 
may possibly come with the disease (Ibid). Type 2 diabetes, cardiovascular diseas-
es and some types of cancer are all obesity related diseases (ibid). The number of 
obese adults increased tremendously between the years 1995 and 2000, with an 
increase of more than 30 % (WHO, 2015a). Meanwhile OECD (2014) reported 
that one in five children in the OECD countries is overweight. WHO declared that 
42 million infants and young children were overweight or obese in 2013 and that 
by 2025, the number will reach to 70 million with the current trend (WHO, 
2015c). In order to break the current trend with the increasing childhood obesity it 
is crucial to take preventive measures at a local, regional and global level (WHO, 
2015d). Such measures should include physical activity, limitations regarding the 
intake of sugars and fats and increasing the intake of fruits, vegetables, legumes 
and whole grains (WG) (ibid).  
 
A simple and established method of measuring overweight and obesity is by using 
the body mass index (BMI) which is the weight (kg) divided by the square of the 
height (m) of a person (Svensson, 2014).  A BMI over 25 is considered to be 
overweight while a BMI over 30 is associated with obesity. The same index can be 
used for children. However, in order to be able to compare children across age and 
gender groups, a modified index is used, BMI SDS (Body Mass Index Standard 
Deviation Score) (Svensson, 2014). BMI SDS is a measure of relative weight and 
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is calculated by using weight, height, age and gender and is based on a reference 
population. 
 
 
1.2   Parental and child obesity 
   Nearly 50 % of the Swedish population is currently overweight or obese and the 
numbers are increasing (Folkhälsomyndigheten, 2014a; SCB, 2012). These num-
bers have increased with more than 13 percent units during the past 20 years. No 
Swedish national data is available for overweight and obesity among children, 
however data from healthcare services show alarming numbers among children 
born 2001-2008, even though the trend do not seem to be increasing (Table 1). 
 
Child obesity is to a high extent heritable, but also dependent of environmental 
factors like parental feeding behaviors (Svensson, 2014; Lo et al., 2015). This is 
causing the children of obese parents to be vulnerable of becoming obese already 
at an early stage of life (Moraeus et al., 2012). The child feeding practices are 
suggested to be an important factor in the fate of the future weight of the children 
(Lo et al., 2015). The diet of the parents is most often given also to their children 
and thus unhealthy eating of the parents will pass on to their children. Many of the 
children that are overweight or obese tend to remain so through adolescence and 
adulthood (Svensson, 2014; Sun Guo et al., 2007). Prevention at an early stage is 
therefore highly effective and crucial (Moraeus et al., 2012). Since obesity is asso-
ciated with a number of chronic diseases such as type 2 diabetes, cardiovascular 
disease (CVD) and cancer, it also increases the mortality rate and thus obese chil-
dren have a lower life expectancy than the average normal weighed child 
(Folkhälsomyndigheten, 2014b).  
 
Table 1. Prevalence of overweight and obesity among children born 2001-2008. Annual report from 
the county council of Stockholm 2013 (Barnhälsovården, 2013.) 
Year of birth           Overweight %      Obesity % 
2001 10.6 2.2 
2002 9.3 2.1 
2003 9.3 1.9 
2004 9.3 1.8 
2005 9.5 1.9 
2006 
2007                                                                  
2008 
9.4 
9.1 
9.4 
1.9 
1.8 
1.8 
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  1.3       Whole grain   
   WG are intact, ground or flaked kernels of cereals, including the bran, the germ 
and the starchy endosperm, or where these components are present in the same 
proportions that naturally occur in the grains (FDA, 2015). Refined grain is based 
on the starch endosperm only. In the refining process, the outer components and 
the germ are excluded. The bran is rich in dietary fiber and associated bioactive 
compounds which are considered to be beneficial for human health (Landberg, 
2009a).  The germ is rich in essential fatty acids, minerals and vitamins. WG foods 
are thus nutritious whereas the refined products contain little beyond starch and 
protein (ibid).  
 
 
 
1.4      Evidence for beneficial health effects of whole grains 
   The Swedish National Food Agency recommends WG instead of refined grains 
whenever cereals are to be consumed, due to the variety of micronutrients that are 
available in the bran (NNR, 2012). WG are also a source of dietary fibers, which 
are considered to be beneficial for health in several ways (Landberg, 2009a). WG 
intake has been associated with reduced risk of developing type 2 diabetes, CVD 
and their preconditions or risk factors, such as weight gain, high blood pressure 
and inflammation as well as cancer (SLV, 2013). The association with weight is 
emphasized in several observational studies (Harland & Garton 2007; Ma et al., 
2012; Steffen et al., 2003). However, several intervention studies show no or mar-
ginal weight loss related to the consumption of WG (Pol et al. 2015). Short-time 
interventions are believed to be the reason behind the conflicting results between 
observational and interventional studies, thus more extensive Randomized control 
trials are necessary to carry out (ibid).  Hitherto there are no intervention studies 
on the role of WG intake of children and the impact on weight. 
 
 
1.5          Methods for whole grain intake assessment 
   Food diaries and food records are commonly used methods to prospectively 
assess the food intake of an individual person or in a household (Landberg, 
2009a). However, these methods have some limitations due to several reasons. For 
example, they result in a high participant-burden which require highly motivated 
participants in order to obtain accurate results. Moreover, over- and under report-
ing is common with these methods as well as memory lapses (Berdanier, Dwyer & 
Heber, 2014; van Dam & Hu, 2015). These and other limitations with self-
reporting methods leads to systematic and random measurement errors in the in-
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take estimation which may in worst case lead to incorrect conclusions in studies 
conducted. A specific problem associated with self-reported intake of WG is the 
difficulty that the consumers may have to recognize WG products among other 
products. Moreover, a uniform definition for WG products is lacking as well as 
food composition data on WG products (Söderholm et al., 2015; van Dam & Hu, 
2015). Due to these problems, WG intake may be challenging to estimate accu-
rately and thus a biomarker may be used as a complement to the dietary assess-
ment method for intake ranking and or as a tool to validate other methods.  
 
 
 
1.6        Alkylresorcinols in whole grains 
   Alkylresorcinols (AR) (Figure 1) are lipophilic phenolic compounds found 
mainly in wheat ( 300-784 µg/g) and rye (568-1231µg/g) among commonly con-
sumed foods. They can also be found in lower amounts in barley (8-210 µg/g) and 
in very low amounts (<5 µg/g) in maize and in garden peas (Landberg, 2009a). 
They are present almost exclusively in the bran and not found in any high amounts 
in the refined flour or in the germ, which makes them to suitable biomarkers for 
WG products (ibid). The AR found in cereal grains mainly consist of saturated 5-
n-alkyl-derivates with odd alkyl chain length, in the range of 17-25 carbon atoms, 
although unsaturated derivates can be found as well (ibid). Rye is the cereal with 
the highest occurrence of unsaturated AR.  
 
 
 
 
 
 
 
Figure 1. Alkylresorcinol C17:0. (Wikipedia) 
 
 
 
 1.7       Alkylresorcinols as biomarkers of whole grain wheat and rye 
in plasma 
  AR are absorbed by humans and have a similar metabolism as tocopherols 
(Marklund et al., 2012). Studies have been conducted to validate AR in plasma as 
biomarkers for WG wheat and rye intake among free-living subjects as well as 
under controlled conditions. These studies have shown that AR reflects WG intake 
adequately in populations with a regular and stable WG intake (Andersson et al., 
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2015). By determining the ratio between two of the AR homologues in plasma, 
C17:0/C21:0, the source of WG can be traced (Landberg, 2009a). The AR 
C17:0/C21:0 ratio is typically ~1.0 in rye, ~0.1 in common wheat and ~0.01 in 
durum wheat (Landberg, 2009a; Chen et al., 2004). The ratio in plasma is to some 
extent determined by other non-dietary factors than the source of WG intake. A 
ratio > 0.15 indicates rye intake to some extent (Ross, 2011). The ratios have been 
shown to reflect trends of WG consumed in plasma from different European coun-
tries (Kyrö et al., 2014). 
 
AR seem to fulfill many of the criteria for being suitable as biomarkers. They re-
main stable under cooking and preparation of foods, are absorbed and metabolized 
similarly in different individuals and are simple to quantify (Söderholm, 2015; 
Landberg et al., 2006). In addition, studies have shown a moderate reproducibility 
over a 2-3 month period (Andersson et al., 2015). However, there are some limita-
tions connected to the use of AR as biomarkers. First, the half-time (t1/2) of intact 
plasma AR are reported to be 5 h, which is a relatively short time considering that 
blood samples usually are collected after a night of fasting (Söderholm et al., 
2015). Along with a short half-life, day to day variation in the WG intake, will 
cause fluctuations which leads to lower precision in estimating the long-term aver-
age AR concentration in plasma, unless intake is frequent and stable (Andersson et 
al., 2011). Currently, studies are ongoing to evaluate AR-metabolites in urine and 
adipose tissue as alternative biomarkers of WG intake (Marklund et al., 2012; 
Wierzbicka et al., 2015).  
 
 
 
1.8        The Early STOPP 
   The Early Stockholm Obesity Prevention Program (STOPP) is an ongoing ran-
domized controlled (RCT) intervention study that aims to prevent children of 
obese or overweight parents to become obese or overweight (Svensson, 2014). 
Families included in the study have been recruited from child healthcare centers in 
Stockholm and both child and parents are included in the study. To be included 
either both parents should be at least overweight or one parent should be obese.  
The study consisted of three treatment groups, an intervention group, a control 
group and a reference group. The control group had similar health background as 
the intervention group but with no interventions. The reference group included 
normal-weighed family members (BMI <25).The intervention started when the 
infants were one year of age and will continue until the children are at the age of 
six. During the course of the study, families have been regularly examined and 
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followed up to obtain data on weight, length/height, BMI and other variables of 
health as well as blood samples after 1, 3 and 6 years. The diet of the families has 
been followed up through annual food diaries. The total number of participating 
families included were 242. Of these, 182 were high risk families and 60 low risk 
families (ibid). For an overview of the experiment see Table 2.  
The intervention has been carried out with the use of coaches to improve the life-
style, dietary habits, physical activities and sleeping patterns of the family in order 
for the child to avoid risk factors that could cause overweight or obesity. The die-
tary recommendations have complied with the general recommendations accord-
ing to SLV (2015). However, the condition of each specific family have been con-
sidered in the coaching process. Thus each family have received a unique dietary 
recommendation and not all families have been advised to increase the WG intake 
(Svensson, 2015 - personal communication). 
 
Table 1. Overivew of the Early STOPP. 
Study group N (families) Parental weight Risk group Intervention 
Intervention 91 Overweight or 
obese 
High Yes 
Control 91 Overweight or 
obese 
High No 
Reference 60 Normal Low No 
 
 
 
1.9    The aim of this study 
The aim of this study was to analyze the concentrations of AR, as biomarkers 
for WG wheat and rye intake, in blood plasma from families that have participated 
in the Early STOPP-project in order to investigate if WG intake of wheat and rye 
(indicated by AR) differed between groups and if it was associated with BMI of 
family members. Moreover, the intake of different WG (assessed by the C17:0/ 
C21:0 ratio) and BMI was also investigated. The hypothesis was that a difference 
in WG wheat and rye intake between groups will be reflected by differences in 
plasma AR concentrations and that AR concentrations will be inversely associated 
with BMI of both children and their parents. If such a correlation exist, a further 
hypothesis was that a high proportion of WG rye over wheat, measured by the AR 
C17:0/C21:0 ratio would be beneficially associated with BMI of parents and chil-
dren. 
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2 Materials and Methods 
2.1     Subjects and samples 
   Plasma samples taken at 3 year follow-ups from families participating in the 
Early STOPP study (227 samples from 115 families) were analyzed for the study. 
The plasma samples and raw data on various variables, as the data from the 1-year 
follow ups, the BMI of the individuals and food diaries, were obtained from the 
Early STOPP investigator team at Karolinska Institutet. All individuals and fami-
lies were encoded.  
 
 
2.2     Analysis of alkylresorcinols in plasma  
Plasma samples were analyzed according to Wierzbicka et al. (2015) with some 
minor changes. Briefly, samples (0.2 mL) were extracted with ether (3*3 mL) and 
put in a dry-ice ethanol batch. The combined extracts were evaporated in a stream 
of nitrogen and dissolved in 1 mL methanol. Samples were purified using Oasis 
®MAX SPE cartridges. The cartridges were conditioned with 0.1M NaOH in 
MeOH (3:7), upon which MeOH was added to the samples in order to elute neutral 
lipids. Finally, formic acid (2%) was added, to elute the AR. Samples were evapo-
rated with a nitrogen stream and then silylated with Trifluoroacetic anhydride 
(TFAA). The samples were finally analyzed with a gas chromatograph mass spec-
trophotometer. In total, 7 batches were analyzed and quality controls (n=4) were 
included in each batch to estimate within and between batch variation. All subjects 
from each family were analyzed in the same batch, to ensure highest precision.  
 
 
2.3     Statistical analysis 
   Plasma AR concentrations were log-transformed in order to improve normality. 
Differences in plasma AR concentration between groups were assessed by one 
way ANOVA after 1 year and 3 years separately. Generalized Linear Model 
(GLM) with sex, family group, BMI of mother and father and total plasma AR 
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concentration as predictors of BMI at 1 or 3 years as response variables in order to 
find potential factors affecting BMI in children at 1 and 3 years of age. Spear-
man’s rank correlation coefficients were calculated for correlations between varia-
bles. Minitab version 16 and SAS version 9.3 were used for statistical analyses. 
P<0.05 was considered statistically significant. 
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3 Results and Discussion 
3.1     Precision for determination of alkylresorcinols 
   The within- and between-batch variations (Table 3) were calculated based on 
four quality control (QC) samples in each batch, except from batch 3, where only 
three QC-samples could be included due to waste of one sample.  
 
The within- and between-batch variation reflects the precision associated with a 
certain method. Random errors are the reason behind precision. A coefficient of 
variation (CV) below 15 % is acceptable precision when assessing AR, consider-
ing the low concentration in plasma. The estimated within- and between-batch 
variation was <15% for all homologues except for C23:0 and C25:0. The high 
variations for these homologues could be due to instrumental discrimination, con-
sidering that these specific homologues have the longest carbon chains and thus 
are the least polar of the homologues with highest boiling point. Due to the long 
lipophilic characteristic of C23:0 and C25:0, losses might have occurred in the 
SPE-purification, when the lipids were eluted from the samples. It is likely that 
these specific homologues performed differently from the other homologues also 
in the quantification in the GC-MS, which has a better sensitivity for low molecu-
lar weight compounds. Both within- and between batch CV: s were considered 
adequate (<20 %). 
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Table 3. Within batch coefficient of variation (%) for different homologues and for total AR in QC-
samples (quality control) for batch 1-8 and between batches coefficient of variation (BB). 
 C17 C19 C21 C23 C25 Total AR 
1 
 
11 3.1 7.9 4.4 14 6.2 
2 8.6 5.8 5.8 6.0 24 6.7 
3 15 8.5 10.6 19.0 29 13 
4 2.1 4.1 2.3 0.98 2.6 2.3 
5 11 10 9.2 5.2 12 6.2 
6 1.7 1.9 2.8 0.38 5.8 1.3 
7 10 6.3 5.2 5.9 5.5 5.8 
8 2.3 3.5 1.6 1.6 2.8 1.5 
BB 11 6.6 5.9 13 19 8.3 
 
 
3.2     The impact of treatment on alkylresorcinols 
   No statistical significant differences in plasma AR concentrations were found 
between the treatment groups (Table 4 and 5). These results are unexpected, since 
the intervention group was expected to have the highest WG intake due to the 
conducted intervention. However, as mentioned, it is possible that not all families 
in the intervention group actually were recommended to increase the WG intake. 
Another possible scenario would be that the subjects did not follow the advice.  
 
The mean AR concentrations appears to have been higher among the 1-year old 
infants compared to when they were 3 years. Since infants mostly consume formu-
la, which seldom consist of wheat and rye, it is unexpected that the AR concentra-
tions were present at such high concentrations. A potential explanation is that in-
fants metabolize AR differently than at the age of 3 years. This should be investi-
gated further. Enzyme activity may differ for children at 1 and 3 years of age. The 
AR C17:0/C21:0 ratio was higher at the measurement at the age of 3 years, which 
indicates that they consumed more rye than when they were 1 year old infants.  
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Table 4. AR concentration in the plasma of the children at the 1 year follow-up. Mean ± SD (Medi-
an). 
 Reference group             Control        Intervention          P-value* 
     
Total AR 275 ± 251 
(221) 
227 ± 181 
(164) 
174 ± 220 
(86) 
0.087 
     
C17:0/C21:0 0.11 ± 0.08    
(0.08) 
0.11 ± 0.07   
(0.10) 
0.13  ±0.10          
(0.12) 
0.887 
*P-value < 0.05 is significant.  
 
Table 5. AR concentration in the plasma of the children at the 3 year follow-up. Mean ± SD (Medi-
an). 
 Reference group             Control        Intervention           P-value* 
     
Total AR 86 ±73 
(65) 
122 ± 137 
(65) 
90 ± 64  
(83) 
 0.834 
     
C17:0/C21:0 0.20  ± 0.13   
(0.16) 
0.20 ± 0.09      
(0.18) 
0.22 ± 0.12              
(0.21) 
             0.725 
 
*P-value < 0.05 is significant. 
 
 
3.3     Factors influencing the BMI of children 
   Total AR in plasma, treatment group, sex or the BMI of the parents were not 
significantly influencing the BMI of the child at the 1 or 3- year follow-up (Table 
6 and 7). The results do not comply with the observational studies on adults, where 
an inverse association between the total AR in plasma and the BMI of the subjects 
have been found (Harland & Garton 2007; Ma et al., 2012; Steffen et al., 2003). A 
suggestion is that the total AR may not reflect the true WG intake since AR as 
biomarkers for WG intake have not been validated in children. This is supported 
by unexpectedly high AR concentrations among children at the age of 1 and lower 
concentrations at the age of 3, despite expectedly higher WG wheat and rye con-
sumption at the age of 3. The type of treatment does not appear to have a signifi-
cant impact on the BMI. This as well indicates that AR may not be suitable as 
biomarkers for WG in children.  
 
The BMI of the parents have no significant impact on the BMI of the children at 
the age of 1 or 3, which is in conflict with studies that have determined the BMI of 
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the parents to correlate with the BMI of the children (Bralic et al., 2005). A possi-
ble explanation for this could be that an eventual weight gain among children in 
the high-risk group of being overweight will come later in life. 
 
Table 6. Factors influencing the BMI of the child at the 1 year follow-up. 
Factor                       P-value* 
Total AR  0.596 
Treatment  0.465 
Sex  0.857 
BMI of father  0.832 
BMI of mother  0.762 
*P-value < 0.05 is significant. 
 
Table 7. Factors influencing the BMI of the child at the 3 year follow-up. 
Factor                       P-value* 
Total AR  0.891 
Treatment  0.295 
Sex  0.194 
BMI of father  0.996 
BMI of mother  0.459 
*P-value < 0.05 is significant. 
 
3.4     Correlations of alkylresorcinols between parents and children 
   The Spearman´s correlation was determined for total AR as well as the AR 
C17:0/C21:0 ratio at the 1- and 3-year follow-ups (Table 8 and 9). A moderate 
positive correlation for total AR in the plasma of the mothers between year 1 and 3 
was observed (Figure 2), as well as for the fathers (Figure 3). The correlation for 
AR C17:0/C21:0 ratio in the plasma of the mothers between year 1 and 3 was 
moderate (Figure 4). The correlations observed shows that the intake among 
parents are rather stable over time and that the relative WG rye to wheat is also 
stable during the  follow-ups.  
 
There is also a moderate positive correlation between the total AR in the plasma of 
the 3-year old children and the fathers year 1 and 3, respectively the mothers year 
1 (Table 8). However, there is no significant correlation between the total AR in 
the 3-year follow-up between the children and the mothers. One explanation could 
be that the diet of the mothers differs between year 1 and 3. The first years follow-
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ing after a childbirth could be a challenging time for the mother, since pregnancy 
and breast-feeding may have an effect on the health and weight of the mother. 
Thus it is not inconceivable that this in turn affects the diets of the mothers, espe-
cially when the period of breast-feeding is at its end. This is however not support-
ed by the positive correlation between the total AR of the mothers between year 1 
and 3, which implies that the WG intake of the mothers stayed constant during the 
follow-ups (Figure 2). The fact that the AR of the 3-year old children seem to cor-
relate with the parents (disregarding from mothers year 3) could imply that AR 
actually reflects the true WG intake. No similar correlation could be found in the 
plasma of the children at the 1-year follow-up and the parents. The results could 
imply that the 3-year old children consumed a similar diet as the parents, assuming 
that the total AR reflects the consumed WG, whereas the 1-year old infants con-
sumed a different diet. However it is highly unlikely that the infants consumed the 
high amounts that the results suggests (Table 4), thus a more likely explanation is 
that AR do not work as a biomarker for WG in infants. 
 
   
Table 8. Spearman´s correlation Total AR year 1 and year 3 for children (C), fathers (F) and mothers 
(M).  (P-value *).  
 C 1 C 3 F 1 F 3 M1 M 3 
       
C 1  -0.14 
(0.453) 
0.07 
(0.536) 
-0.15 
(0.409) 
0.04 
(0.720) 
0.09 
(0.577) 
C 3   0.51 
(0.007) 
0.36 
(0.044) 
 
0.42 
(0.016) 
0.19 
(0.237) 
       
*P-value < 0.05 is significant. 
 
 
Table 9. Spearman´s correlation C17:0/C21:0 year 1 and year 3 for children (C), fathers (F) and 
mothers (M). (P-value*). 
 C 1 C 3 F 1 F 3 M1 M 3 
C 1  0.03 
(0.867) 
0.05 
(0.644) 
0.05 
(0.804) 
0.23 
(0.019) 
0.10 
(0.558) 
C 3   0.14 
(0.506) 
0.40 
(0.059) 
0.27 
(0.140) 
 
-0.03 
(0.888) 
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*P-value < 0.05 is significant. 
 
 
Figure 2. Total AR concentration (nmol/l) in plasma from mothers at the 1- and 3- year follow-ups. 
Spearman’s r = 0.43 (P = 0.003) and was based on 45 persons due to missing data. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Total AR concentration (nmol/l) in plasma from fathers at the 1- and 3- year follow-ups. 
Spearman’s r = 0.43 (P = 0.021) and was based on 29 persons due to missing data. One abnormal 
value (531) was excluded from the graph. 
y= 0.684x+17.738 
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Figure 4. AR C17:0/C21:0 ratio in plasma from mothers at the 1- and the 3-year follow-ups. 
Spearman’s r = 0.43 (P = 0.006) and was based on 39 persons due to missing data. 
 
3.5     The validity of plasma alkylresorcinol concentrations as a bi-
omarker of whole grain wheat and rye intake in children 
   No statistical significant correlation between the self-reported WG intake (total 
or the sum of wheat, rye and barley) and total AR was observed for the children at 
the 3-year follow-up (Table 10). Moreover, no significant correlation between the 
declared WG intake (general or wheat, rye and barley) and the assessed AR 
C17:0/C: 21:0 ratio was observed. This is in contrast to many studies conducted in 
adults under controlled and free-living conditions (Andersson et al., 2015; Ross, 
2011).  
 
As stated, self-declared food diaries can be deceiving since under and over reports 
are commonly occurring sources of errors. Specific difficulties in the food declara-
tion of children could also further aggravate the method. Parents of small children 
can be expected to have less time and thus do not have time to prioritize the food 
diaries. Moreover, parents may feel ashamed if they do not feed their children 
y= 0.1536x+0.1354 
 
AR C17:0/C21:0 Ratio Mothers 
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healthy food, which in turn could cause them to misreport and claim that they con-
sumed more WG than they actually did.  
 
Plasma AR concentration in children may be affected by other factors than diet to 
a larger extent than for adults. This may be a reason for the lack of a correlation 
between reported intake and plasma AR. This is supported by the fact that children 
at one year old has 5-10 times higher AR concentrations than their parents.  
  
Since there are no previous studies on AR as biomarkers for WG in children, the 
only available values to use in comparison are from adults. The studies on adults 
show a good validity concerning AR as biomarkers for WG. The results however 
only applies to adults, thus infants or small children may have a different metabo-
lism and absorption of AR. This needs further investigations. 
 
Table 10. Spearman´s correlation between self-declared WG intake and AR concentrations in the 
plasma of the children at the 3 year follow-up and P-value* in parenthesis. Correlation was based 
on data from 51 children.  
 Total AR C17:0/C21:0 
WG intake 0.14 
(0.346) 
 
0.17 
(0.223) 
WG intake (Wheat, 
rye & barley) 
0.23 
(0.112) 
0.24 
(0.090) 
 
*P-value < 0.05 is significant. 
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4 Conclusion 
 
No significant correlations between the AR concentrations in the plasma of the 
children and their BMI at 1 or 3 year of age was observed. Moderate positive 
correlations for total AR in plasma were found between the 3-year old children 
and the mothers and fathers at the 1-year follow-up, as well as the fathers at the 3-
year follow-up, which could imply that the AR reflects the true WG intake in 3-
year old children. However, no correlation between the assessed AR and the self-
declared WG intake was found in the 3-year follow-up. This implies that AR are 
not suitable as biomarkers for WG intake in children, possibly due to other factors 
than intake that may be important for the plasma AR concentration among 
children. Such factors could be related to the metabolism of AR.   
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